The combination of HB-EGF and BM-MSC administration intravenously in rat models of NEC leads to the best improvement in intestinal barrier function and survival compared to HB-EGF or BM-MSC administrated alone [14]. The gene discussed is HBEGF; the disease is necrotizing enterocolitis.